Compare CLPR & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLPR | MYO |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 44.8M |
| IPO Year | 2015 | 2017 |
| Metric | CLPR | MYO |
|---|---|---|
| Price | $2.74 | $1.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 38.8K | ★ 312.6K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $109,997,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 5.82 | ★ 40814.79 |
| 52 Week Low | $2.69 | $0.61 |
| 52 Week High | $4.61 | $1.99 |
| Indicator | CLPR | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 36.11 | 51.38 |
| Support Level | $2.69 | $0.90 |
| Resistance Level | $2.95 | $1.17 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 20.83 | 77.07 |
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.